Form 4 Tracker
Stoke Therapeutics, Inc.
STOK

35 insider filings · Latest: Aug 3, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Oct 3, 2025Oct 3 8:30 PMJONATHAN ALLAN
Proposed Sale
10,000$24.82$248.2K

View →

Sep 2, 2025Sep 2 8:37 PMBARUCH TICHO
Proposed Sale
10,844$19.76$214.3K

View →

Aug 29, 2025Aug 29 8:17 PMEDWARD M KAYE
Proposed Sale
61,885$19.77$1.2M

View →

Aug 29, 2025Aug 29 8:17 PMJONATHAN ALLAN
Proposed Sale
22,117$19.77$437.3K

View →

Aug 13, 2025Aug 13 8:29 PMJONATHAN ALLAN
Proposed Sale
13,712$13.53$185.5K

View →

Jul 1, 2025Jul 1 8:27 PMBARUCH TICHO
Proposed Sale
9,007$11.35$102.2K

View →

May 1, 2025May 1 8:45 PMBARUCH S. TICHO
Proposed Sale
34,847$9.76$340.1K

View →

Dec 23, 2024Dec 23 11:15 PMBlue Horizon Enterprise Ltd
Proposed Sale
2,000,000$11.59$23.2M

View →

Dec 9, 2024Dec 9 9:48 PMJONATHAN ALLAN
Proposed Sale
12,114$13.27$160.8K

View →

Nov 1, 2024Nov 1 8:50 PMBARUCH TICHO
Proposed Sale
20,000$12.36$247.2K

View →

Sep 19, 2024Sep 19 9:23 PMBlue Horizon E LTD
Proposed Sale
1,937,500$15.22$29.5M

View →

← Previous

Page 3 of 3

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Feb 17, 2026Feb 19 9:22 PMThomas LeggettChief Financial Officer
Grant/Award
100,000$31.0940,000(D)

View →

Feb 17, 2026Feb 19 9:21 PMJason HoittChief Patient Officer
Grant/Award
120,000$31.0948,000(D)

View →

Feb 17, 2026Feb 19 9:20 PMJonathan AllanGENERAL COUNSEL & CORP SEC
Grant/Award
88,000$31.0935,000(D)

View →

← Previous

Page 2 of 2